| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.5 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |